PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

KH Neochem Co., Ltd.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

KH Neochem Co., Ltd. owes ¥0.41 for every ¥1 it owns. Net profit fell 7% in the year to Dec 2025, and shrank 1% a year on average over 3 years.

Compared with Basic Materials companies in Japan · latest annual results Dec 2025.

P/E ratio

13.3

Investors pay ¥13.3 for every ¥1 of KH Neochem Co., Ltd.'s yearly profit, higher than 59% of Basic Materials companies in Japan.

P/B ratio

1.60

The share price is 1.60 times KH Neochem Co., Ltd.'s book value per share, higher than 86% of Basic Materials companies in Japan.

Market cap

¥119.2 B

The total market value of all of KH Neochem Co., Ltd.'s shares at today's price (share price × number of shares), larger than 71% of Basic Materials companies in Japan. PosiCap size class: Mini Cap.

Net worth (book value)

¥74.7 B

What KH Neochem Co., Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

¥2,132

Net worth divided by the number of shares. The share price of ¥3,405 is 1.6 times this, which is the P/B above.

Return on equity (ROE)

12.6%

KH Neochem Co., Ltd. earned 12.6% on its shareholders' money over the last year, higher than 82% of Basic Materials companies in Japan.

Owes vs Owns

0.41×

KH Neochem Co., Ltd. owes ¥0.41 for every ¥1 it owns (low).

Dividend yield

4.48%

KH Neochem Co., Ltd. pays 4.48% of its share price as dividends a year, higher than 83% of dividend-paying Basic Materials companies in Japan.

Revenue growth

-4%

Revenue fell 4% in the year to Dec 2025, and grew 0% a year on average over 3 years.

Profit growth

-7%

Net profit fell 7% in the year to Dec 2025, and shrank 1% a year on average over 3 years.

Profit margin

6.8%

KH Neochem Co., Ltd. keeps ¥7 of every ¥100 of revenue as net profit.

Cash quality

1.8×

Cash from KH Neochem Co., Ltd.'s business was 1.8× its reported profit in the year to Dec 2025 — its profit turned into cash.

Interest cover

57.1×

KH Neochem Co., Ltd.'s operating profit covered its interest costs 57.1 times in the year to Dec 2025.

Cash vs debt

Net debt

KH Neochem Co., Ltd. had ¥11.6 B more debt than cash (net debt) at Dec 2025.

Questions

What is KH Neochem Co., Ltd.'s P/E ratio?

Investors pay ¥13.3 for every ¥1 of KH Neochem Co., Ltd.'s yearly profit, higher than 59% of Basic Materials companies in Japan.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For KH Neochem Co., Ltd.: ¥119.2 B ÷ ¥74.7 B (30 Jun 2026) = 1.6.

What is KH Neochem Co., Ltd.'s return on equity?

KH Neochem Co., Ltd. earned 12.6% on its shareholders' money over the last year, higher than 82% of Basic Materials companies in Japan.

How much does KH Neochem Co., Ltd. owe compared with what it owns?

KH Neochem Co., Ltd. owes ¥0.41 for every ¥1 it owns (low).

Does KH Neochem Co., Ltd. pay a dividend?

Yes. KH Neochem Co., Ltd. pays 4.48% of its share price as dividends a year, higher than 83% of dividend-paying Basic Materials companies in Japan.

Is KH Neochem Co., Ltd.'s revenue growing?

Revenue fell 4% in the year to Dec 2025, and grew 0% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.